Nifurtimox for chagas disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 11 Jun 2019: Trial registered, NCT03981523
  2. 18 Dec 2019: Trial started, NCT03981523

The trials

NCT02369978: CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)

State
State not given
Phase
Phase 2 and Phase 3
People
500 planned
Started
Aug 2015
Primary completion
Aug 2018
Arms
Nifurtimox (NFX)
Results
None posted
  1. 24 Feb 2015: Trial registered

NCT03981523: New Therapies and Biomarkers for Chagas Infection

State
Completed
Phase
Phase 2
People
450 taking part
Started
18 Dec 2019
Primary completion
29 May 2024
Arms
NFX-60, NFX-30, NFX-90
Results
None posted
  1. 11 Jun 2019: Trial registered
  2. 18 Dec 2019: Trial started
  3. 31 May 2024: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Lampit.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.